RE: More positive PR from the BoD of Scancell22 Dec 2025 15:31
I remember an AIM BIO share I had a few years ago with a valuation of around £100m that did a placing at a 10% premium to the share price to fund the next stage of their trials, the reaction was quite something, doubled in a couple of days and tripled after a week or so.
There seems to be a struggle between the retail investors here, some believe a placing, some believe a partnership or buyout.
Either way the results so far would indicate that if there was to be a placing, it could easily be at a premium to the current share price.
I’m holding and adding either way.
Happy Xmas and new year to all.